1. Anderson, G. W., Slone, T. W., Jr., and Peters, C.J., 1988, The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis, Arch. Virol.
102:187.
2. Arthur, R. R., Said El-Sharkawy, M., Cope, S. E., Botros, B. A., Oun, S., Morrill, J. C., Shope, R. E., Hibbs, R. G., Darwish, M. A., and Imam, I. Z. E., 1993, Recurrence of Rift Valley fever in Egypt, Lancet
342:1149.
3. Assad, F., Davies, R. G., Eddy, G. A., El Karamany, R., Meegan, J. M., Ozawa, Y., Shimshony, A., Shope, R. E., Walker, J., and Yedloutschnig, R. J., 1983, The use of veterinary vaccines for prevention and control of Rift Valley fever: Memorandum from a WHO/FAO meeting, Bull. WHO
61:261.
4. Biosafety in Microbiological and Biomedical Laboratories, 1993, HHS Publication No. (CDC) 93-8395, U.S. Department of Health and Human Services, 3rd ed., May, p. 130.
5. Caplen, H., Peters, C. J., and Bishop, D. H. L., 1985, Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development, J. Gen. Virol.
66:2271.